Cargando…
Lymphotoxin α revisited: general features and implications in rheumatoid arthritis
Rheumatoid arthritis (RA) is a chronic inflammatory disease affecting synovial joints. Therapies blocking tumor necrosis factor-alpha (TNFα) are now routinely used in the management of RA. However, a significant number of patients with RA do not respond or develop resistance to anti-TNF therapies, a...
Autores principales: | Calmon-Hamaty, Flavia, Combe, Bernard, Hahne, Michael, Morel, Jacques |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3239340/ https://www.ncbi.nlm.nih.gov/pubmed/21861866 http://dx.doi.org/10.1186/ar3376 |
Ejemplares similares
-
Apoptosis is not the major death mechanism induced by celecoxib on rheumatoid arthritis synovial fibroblasts
por: Audo, Rachel, et al.
Publicado: (2007) -
IL-10 Producing B Cells Ability to Induce Regulatory T Cells Is Maintained in Rheumatoid Arthritis
por: Mielle, Julie, et al.
Publicado: (2018) -
Lymphotoxin-LIGHT Pathway Regulates the Interferon Signature in Rheumatoid Arthritis
por: Bienkowska, Jadwiga, et al.
Publicado: (2014) -
High levels of memory B cells are associated with response to a first tumor necrosis factor inhibitor in patients with rheumatoid arthritis in a longitudinal prospective study
por: Daien, Claire I, et al.
Publicado: (2014) -
Osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as prognostic factors in rheumatoid arthritis: results from the ESPOIR cohort
por: Audo, Rachel, et al.
Publicado: (2015)